- Technical breakdown looks ugly but biting the bullet with a strong conviction that bad news are priced in.
- Risk is to the upside. Even if it goes down, I'm mentally ready to buy more of
UNH and let it compound for years to come.
- I believe that we should close the gap above @ $376 so we have around 35-40% upside by the year end.
- Risk is to the upside. Even if it goes down, I'm mentally ready to buy more of
- I believe that we should close the gap above @ $376 so we have around 35-40% upside by the year end.
Note
Bought 
Note
Bought 
Note
My conviction is that Note
I'm targeting $380-400 in less than one year from now! Note
Morgan Stanley Price Target: $342.00Rating : Overweight
Note
- Risk to the upside is greater than the risk to the downside.- Risk/Reward suggests accumulating stock before earnings and trust the CEO.
- CEO has solid proven expertise in navigating the behemoth company like
Note
- Scared money makes no money! - CEO has put 25 million on the line. Have some balls folks!
Note
Some people like Snake Ackman are short on their position who are paying their cheap misinformation campaignist to recycle the same old news almost 5 times now.
Buy the dip! This is nothing burger. Things will settle down on Monday .
Note
- Imagine getting punishing for being transparent and being proactively reaching out to DOJ to let them know if they need anything company will proactively work with them to resolve any concerns they have.- Algos are programmed to sell even if the same shit news wrapped up in the different wrapper
Note
I'm not selling a single share of mine. Y'all can chicken out if you want. My calculation says it's already discounted for the dooms day. Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.